Amherst, NY, United States of America

Charles T Taverner

This inventor holds 2 USPTO granted patents. Top assignees: Medtek Devices, Inc., Other. Active years: 1996-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles T Taverner. Retrieved from https://idiyas.com/inventor/charles-t-taverner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1996-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Charles T Taverner - Pioneering Inventor from Amherst, NY

Introduction: Charles T Taverner is a renowned inventor hailing from Amherst, NY, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Charles T Taverner holds several patents in diverse areas such as technology, healthcare, and consumer products, showcasing his versatility and ingenuity in inventing novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Charles T Taverner has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries and improving the lives of countless individuals around the world.

Collaborations: Charles T Taverner has collaborated with leading companies, research institutions, and universities to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Charles T Taverner's passion for innovation and his relentless pursuit of excellence have established him as a trailblazing inventor whose impact will be felt for generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…